Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CallisonRTKL (formerly RTKL) is a global architecture, planning, and design firm that serves as a major infrastructure partner to the healthcare and life sciences sectors. While not a drug developer, the firm is a key player in the biotech ecosystem, specializing in the design of BSL-rated laboratories, pharmaceutical manufacturing facilities, and large-scale academic medical centers. Their Science + Technology group consults for major pharmaceutical and biotechnology entities to create high-performance R&D environments that meet stringent regulatory and operational requirements. The company operates as a subsidiary of the global design and consultancy firm Arcadis, integrating sustainable design and advanced technology into healthcare infrastructure projects worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RTKL.